Skip to main content
SpringerLink
Log in

Clinical significance of red cell blood groups

  • Chapter
Supportive therapy in haematology

  • 103 Accesses

Abstract

Since the discovery [1] of the ABO blood group system in 1900, more than 400 additional red cell blood group antigens have been identified [2]. Obviously, in a chapter of this length very few of the known complexities can be described. In clinical medicine the major importance of the antigens is the role they play in red cell transfusions. Accordingly, in this chapter an attempt is made to describe the antigens predominantly in that setting. Other aspects of the red cell blood groups as they pertain to certain disease states are mentioned and in some instances brief details about the biochemistry, genetics, serology and immunology of the blood group systems are given in an attempt to make the role of these systems in transfusion therapy more comprehensible. While the stress of the chapter is placed on the role of the blood groups in transfusion, the contributions made from study of the blood groups, in other areas of science, should not be forgotten. Much has been learned about human genetics from studies on how the blood group antigens are inherited. This knowledge is now applied to cases in which parentage is disuputed. By using red and white cell blood group markers it is now possible to exclude individuals from paternity and where no exclusion exists, to use gene frequency calculations to provide strong evidence of parentage. Studies on the biochemical structure of proteins, glycoproteins and glycolipids that carry red blood cell antigens have contributed significantly to the current understanding of the structure and function of cell membranes. The way in which individuals respond to exposure to foreign antigens on red cells has contributed to understandings of the immune system in man. There is no doubt that the survival of renal allografts is considerably better in patients who have been transfused before engraftment than in those who have not. However, this beneficial effect seems to be related to the general immune response to the transfusion of blood (perhaps to the leukocytes contained therein) and not to involve a response to any particular red cell blood group antigen [3]. Accordingly, this subject is discussed in more detail elsewhere in this book.

This chapter was completed in December, 1983.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Landsteiner K: Zur kenntnis der antifermentativen, lytischen und agglutinierenden wirkungen des blutserums und der lymphe. Zbl Bakt, 1900; 27: 357–62 (English translation, Blood Transfusion Division, U.S. Army Medical Research Laboratory, Fort Knox, Kentucky).

    Google Scholar 

  2. Issitt PD, Issitt CH: Applied Blood Group Serology, 2nd ed. Oxnard, Spectra Biologicals, 1975.

    Google Scholar 

  3. Cicciarelli J, Terasaki PI: Immunological aspects of HLA, crossmatching and transfusion in kidney transplantation. In: Blood Group Antigens and Disease, Garratty G (ed). Arlington, Va., American Association of Blood Banks, 1983: 149–64.

    Google Scholar 

  4. Garratty G: The role of compatibility tests. Report of a meeting sponsored by the Bureau of Biologics for the Blood Products Advisory Committee. Transfusion, 1982; 22: 169–72.

    Article  PubMed  CAS  Google Scholar 

  5. Honig CL, Bove JR: Transfusion-associated fatalities: review of Bureau of Biologics reports 1976–1978. Transfusion, 1980; 20: 653–61.

    Article  PubMed  CAS  Google Scholar 

  6. Mollison PL: Blood Transfusion in Clinical Medicine, 7th ed. Oxford, Blackwell, 1983.

    Google Scholar 

  7. Rosati LA, Barnes B, Oberman HA, Penner JA: Hemolytic anemia due to anti-A in concentrated antihemophilic factor preparations. Transfusion, 1979; 10: 139–41.

    Article  Google Scholar 

  8. Watkins WM, Morgan WTJ: Possible genetic pathways for the biosynthesis of blood group mucopolysaccharides. Vox Sang, 1959; 4: 97–119.

    Article  PubMed  CAS  Google Scholar 

  9. Davey RJ, Tourault MA, Holland PV: The clinical significance of anti-H in an individual with the Oh (Bombay) phenotype. Transfusion, 1978; 18: 738–42.

    Article  PubMed  CAS  Google Scholar 

  10. Salmon C: A tentative approach to variations in ABH and associated erythrocyte antigens. Ser Haematol, 1969; II; 3.

    Google Scholar 

  11. Issitt PD: Serology and Genetics of the Rhesus Blood Group System. Cincinnati, Montgomery, 1979.

    Google Scholar 

  12. Pollack W, Ascari WQ, Kochesky RJ, O’Connor RR, Ho TY, Tripodi D: Studies on Rh prophylaxis. I. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion, 1971; 11: 333–39.

    Article  PubMed  CAS  Google Scholar 

  13. McMaster Conference. Prevention of Rh immunization. Vox Sang, 1977; 36: 50–64.

    Google Scholar 

  14. Tovey LAD, Murray J, Stevenson BJ, Taverner JM: Prevention of Rh haemolytic disease. Br Med J, 1978; 2: 106–8.

    Article  PubMed  CAS  Google Scholar 

  15. Marsh WL: The Kell blood groups and their relationship to chronic granulomatous disease. In: Cellular Antigens and Disease, Steane EA (ed). Washington, D.C., American Association of Blood Banks, 1977: 52–66.

    Google Scholar 

  16. Schwartz SA, Marsh WL, Symmans A, Johnson CL, Mueller KA: ‘New’ clinical features of McLeod syndrome. Transfusion, 1982; 22: 404 (abstract).

    Google Scholar 

  17. McGinniss MH, Miller LH: Malaria, erythrocyte receptors and the Duffy blood group system. In: Cellular Antigens and Disease, Steane EA (ed). Washington, D.C., American Association of Blood Banks, 1977: 67–77.

    Google Scholar 

  18. Issitt PD: The MN Blood Group System. Cincinnati, Montgomery, 1981.

    Google Scholar 

  19. Pasvol G, Jungery M, Weatherall DJ, Parsons SF, Anstee DJ, Tanner MJA: Glycophorin as a possible receptor for Plasmodium falciparum. Lancet, 1982; 2: 947–51.

    Article  PubMed  CAS  Google Scholar 

  20. Cutbush M, Mollison PL: Relation between characteristics of blood-group antibodies in vitro and associated patterns of red cell destruction in vivo. Br J Haematol, 1958; 4: 115–37.

    Article  Google Scholar 

  21. Mollison PL: Blood group antibodies and red cell destruction. Br Med J, 1959; 2: 1035–41.

    Article  PubMed  CAS  Google Scholar 

  22. Mollison PL: Blood group antibodies and red cell destruction. Br Med J, 1959; 2: 1123–30.

    Article  PubMed  CAS  Google Scholar 

  23. Mollison PL: Factors determining the relative clinical importance of different blood-group antibodies. Br Med Bull, 1959; 15: 92–98.

    PubMed  CAS  Google Scholar 

  24. Mollison PL: Further studies on the removal of incompatible red cells from the circulation. Acta Hemat Fasc 10 Basel, Karger, 1959: 495–500.

    Google Scholar 

  25. Giblett ER: Blood group alloantibodies: an assessment of some laboratory practices. Transfusion, 1977; 17: 299–308.

    Article  PubMed  CAS  Google Scholar 

  26. Mollison PL, Johnson CA, Prior DM: Dose-dependent destruction of A1 cells by anti-A1. Vox Sang, 1978; 35: 14953.

    Article  Google Scholar 

  27. Morel PA, Garratty G, Perkins HA: Clinically significant and insignificant antibodies in blood transfusion. Am J Med Technol, 1978; 44: 122–29.

    PubMed  CAS  Google Scholar 

  28. Cronin CA, Pohl BA, Miller WV: Crossmatch-compatible blood for patients with anti-P1. Transfusion, 1978; 18: 7 2830.

    Google Scholar 

  29. Issitt PD: Antibodies reactive at 30°C, room temperature and below. In: Clinically Significant and Insignificant Antibodies, Butch SH, Beck ML (eds). Washington D.C., American Association of Blood Banks, 1979: 13–28.

    Google Scholar 

  30. Waheed A, Kennedy MS, Gerhan S, Senhauser DA: Transfusion significance of Lewis system antibodies. Success in transfusion with crossmatch-compatible blood. Am J Clin Pathol, 1981; 76: 294–98.

    PubMed  CAS  Google Scholar 

  31. Standards for Blood Banks and Transfusion Services, 10th Ed. American Association of Blood Banks, Washington D.C., 1981: 27.

    Google Scholar 

  32. Technical Manual of the American Association of Blood Banks, 8th Ed, Widmann F (ed). American Association of Blood Banks, Washington D.C., 1981: 177–82, 211–13.

    Google Scholar 

  33. Petz LD, Swisher SN: Clinical Practice of Blood Transfusion. Churchill Livingstone, New York, 1981: 171,182, 183, 191.

    Google Scholar 

  34. Kurtz SR, Ouellet R, McMican A, Valeri CR: Survival of MM cells during hypothermia in two patients with anti-M. Transfusion, 1983; 23: 37–39.

    Article  PubMed  CAS  Google Scholar 

  35. Helgeson M, Swanson J, Polesky HF: Knops-Helgeson (Kna), a high-frequency erythrocyte antigen. Transfusion, 1970; 10: 137–38.

    Article  PubMed  CAS  Google Scholar 

  36. Colledge KI, Kaplan HS, Marsh WL: Massive transfusion of Sd(a+) blood to a recipient with anti-Sda without clinical complication. Transfusion, 1973; 13: 340 (abstract).

    Google Scholar 

  37. Moore HC, Issitt PD, Pavone BG: Successful transfusion of Ch(a+) blood to two patients with anti-Cha. Transfusion, 1975; 15: 266–69.

    Article  PubMed  CAS  Google Scholar 

  38. Wells RF, Korn G, Hafleigh B, Grumet FC: Characterization of three new apparently related high frequency antigens. Transfusion, 1976; 16: 427–33.

    Article  PubMed  CAS  Google Scholar 

  39. Tilley CA, Crookston MC, Haddad SA, Shumak KH: Red blood cell survival studies in patients with anti-Cha, anti-Yka, anti-Ge and anti-Vel. Transfusion, 1977; 17: 169–72.

    Article  PubMed  CAS  Google Scholar 

  40. Silvergleid AJ, Wells RF, Hafleigh EB, Korn G, Keller RT, Grumet FC: Compatibility tests using 51Cr-labeled red blood cells in crossmatch positive patients. Transfusion, 1978; 18: 8–14.

    Article  PubMed  CAS  Google Scholar 

  41. Sabo B, Moulds JJ, McCreary J: Anti-JMH: another high titer low avidity antibody against a high frequency antigen. Transfusion, 1978; 18: 387 (abstract).

    Google Scholar 

  42. Shore GM, Steane EA: Survival of incompatible red cells in a patient with anti-Csa and three other patients with antibodies to high frequency red cell antigens. Transfusion, 1978; 18: 387 (abstract).

    Google Scholar 

  43. Nordhagen R, Aas M: Survival studies of 51Cr Ch(a+) red cells in a patient with anti-Cha and massive transfusion of incompatible blood. Vox Sang, 1979; 37: 179–81.

    Article  PubMed  CAS  Google Scholar 

  44. Garratty G: Clinical significance of antibodies reacting optimally at 37C. In: Clinically Significant and Insignificant Antibodies, Butch SH, Beck ML (eds). Washington, D.C., American Association of Blood Banks, 1979: 29–49.

    Google Scholar 

  45. Ryden SE: Successful transfusion of a patient with anti-Yka. Transfusion, 1981; 21: 130–31 (letter).

    Article  PubMed  CAS  Google Scholar 

  46. Viggiano E, Ballas SK: Erythrocyte survival studies of ‘Kna/McCa’ incompatible blood in a patient with anti-‘Kna/ McCa’. Transfusion, 1981; 21: 603 (abstract).

    Google Scholar 

  47. Valko DA, Silberstein EB, Greenwalt TJ, Issitt PD: Normal survival of in vitro reactive red cells in one patient with anti-McCa and one with anti-Csa. Transfusion, 1981; 21: 603–4 (abstract).

    Google Scholar 

  48. Grove W, Peters B, Ellisor SS, Vanderbilt-Tate TJ: Normal 51Cr red cell survival of York (Yka) positive blood in a patient with anti-Yka. Transfusion, 1981; 21: 607–8 (abstract).

    Google Scholar 

  49. Issitt PD: The clinical significance of some anti-red cell antibodies. In: Advances in Pathology, Antatomic and Clinical, Part I, Levy E (ed). Oxford, Pergamon, 1982: 395–398.

    Google Scholar 

  50. Harpool DR: Anti-S1a: lack of effect on transfused S1(a+) red cells. Transfusion, 1983; 23: 402–3 (letter).

    Article  PubMed  CAS  Google Scholar 

  51. Bettigole R, Harris JP, Tegoli J, Issitt PD: Rapid in vivo destruction of Yt(a+) red cells in a patient with anti-Yta. Vox Sang, 1968; 14: 143–46.

    Article  PubMed  CAS  Google Scholar 

  52. Dubbs JV, Prutting DL, Adebahr ME, Allen FH Jr: Clinical experience with three examples of anti-Yta. Vox Sang, 1968; 15: 216–21.

    Article  Google Scholar 

  53. Gobel U, Drescher KH, Pottgen W, Lehr H: A second example of anti-Yta with rapid in vivo destruction of Yt(a+) red cells. Vox Sang, 1974; 27: 171–75.

    Article  PubMed  CAS  Google Scholar 

  54. Zettner A, Bove JR: Hemolytic transfusion reaction due to interdonor incompatibility. Transfusion, 1963; 3: 48–51.

    Article  PubMed  CAS  Google Scholar 

  55. Franciosi R, Awer E, Santana M: Interdonor incompatibility resulting in anuria. Transfusion, 1967; 7: 297–98.

    Article  PubMed  CAS  Google Scholar 

  56. Abbott D, Hussain S: Intravascular coagulation due to inter-donor incompatibility. Can Med Assoc J, 1970; 103: 752–56.

    PubMed  CAS  Google Scholar 

  57. Morse EE: Interdonor incompatibility as a cause of reaction during granulocyte transfusion. Vox Sang, 1978; 35: 215–18.

    Article  PubMed  CAS  Google Scholar 

  58. Goldfinger D, Kleinman S, Connelly M, Chaux A, Sacks HJ: Acute hemolytic transfusion reaction (HTR) with disseminated intravascular coagulation (DIC) and acute renal failure (ARF) due to transfusion of plasma containing Rh antibodies. Transfusion, 1979; 19: 639–40 (abstract).

    Google Scholar 

  59. Anonymous referee of the first draft of this chapter, 1983.

    Google Scholar 

  60. Issitt PD: Red cell transfusions in autoimmunized patients. Cleveland Clinic Quart, 1981; 48: 289–303.

    CAS  Google Scholar 

  61. Petz LD, Garratty G: Acquired Immune Hemolytic Anemias. New York, Churchill Livingstone, 1980.

    Google Scholar 

  62. Race RR, Sanger R: Blood Groups in Man, 6th Ed. Oxford, Blackwell, 1975.

    Google Scholar 

Download references

Authors
  1. P. D. Issitt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Red Cross Blood Bank, Groningen-Drenthe, The Netherlands

    P. C. Das  & C. Th. Smit Sibinga  & 

  2. Dept. of Haematology, University Hospital, Groningen, The Netherlands

    M. R. Halie

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishers. Boston/Dordrecht/Lancaster

About this chapter

Cite this chapter

Issitt, P.D. (1985). Clinical significance of red cell blood groups. In: Das, P.C., Sibinga, C.T.S., Halie, M.R. (eds) Supportive therapy in haematology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2577-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2577-2_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9617-1

  • Online ISBN: 978-1-4613-2577-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation